Patient characteristics by primary method of recurrence detection
| All patients | Tumor marker | Scan | Surgery | Symptoms | P value | |
| n=147 | n=46 | n=81 | n=3 | n=17 | ||
| Age | 0.911 | |||||
| <60 years | 54 (37%) | 18 (39%) | 28 (35%) | 1 (33%) | 7 (41%) | |
| ≥60 years | 93 (63%) | 28 (61%) | 53 (65%) | 2 (67%) | 10 (59%) | |
| Race | 0.989 | |||||
| White | 107 (73%) | 33 (72%) | 57 (70%) | 3 (100%) | 14 (82%) | |
| Asian | 13 (9%) | 3 (6.5%) | 8 (9.9%) | 0 (0%) | 2 (12%) | |
| Black | 11 (7%) | 4 (8.7%) | 7 (8.6%) | 0 (0%) | 0 (0.00%) | |
| Not reported | 13 (9%) | 5 (11%) | 7 (8.6%) | 0 (0%) | 1 (6%) | |
| Other | 3 (2%) | 1 (2.2%) | 2 (2.5%) | 0 (0%) | 0 (0.00%) | |
| BMI | 0.795 | |||||
| <30 kg/m2 | 113 (77%) | 34 (74%) | 63 (78%) | 2 (67%) | 14 (82%) | |
| ≥30 kg/m2 | 34 (23%) | 12 (26%) | 18 (22%) | 1 (33%) | 3 (18%) | |
| At least two comorbidities | 0.264 | |||||
| No | 101 (69%) | 30 (65%) | 54 (67%) | 2 (67%) | 15 (88%) | |
| Yes | 46 (31%) | 16 (35%) | 27 (33%) | 1 (33%) | 2 (12%) | |
| BRCA status | 0.149 | |||||
| Negative | 105 (71%) | 35 (76%) | 58 (72%) | 2 (67%) | 10 (59%) | |
| Positive | 17 (12%) | 8 (17%) | 8 (9.9%) | 0 (0%) | 1 (6%) | |
| Unknown | 22 (15%) | 3 (6.5%) | 12 (15%) | 1 (33%) | 6 (35%) | |
| VUS | 3 (2%) | 0 (0%) | 3 (3.7%) | 0 (0%) | 0 (0.00%) | |
| Insurance type | 0.871 | |||||
| Commercial | 129 (88%) | 39 (85%) | 72 (89%) | 3 (100%) | 15 (88%) | |
| Public | 17 (12%) | 7 (15%) | 8 (9.9%) | 0 (0%) | 2 (12%) | |
| Uninsured | 1 (0.7%) | 0 (0%) | 1 (1.2%) | 0 (0%) | 0 (0%) |
BMI, body mass index; VUS, variants of uncertain significance.